Top Markets
#1 Black Phoenix Black Phoenix +736.78%
#2 Beam Beam +33.31%
#3 SAFEcoin SAFEcoin +19.80%
#4 THORChain THORChain +18.15%
#5 Tutorial Tutorial +17.03%
#6 Bless Bless +15.48%
#7 TENDIES TENDIES +15.42%
#8 EfficientFrontier EfficientFrontier +15.28%
#9 THORChain Yield THORChain Yield +13.62%
#10 Versatize Coin Versatize Coin +12.49%
Coin of the day
Black Phoenix Black Phoenix
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Rapport Therapeutics, Inc. Common Stock Rapport Therapeutics, Inc. Common Stock

Rapport Therapeutics, Inc. Common Stock

RAPP
Classifica tra le azioni #5670
Rapport Therapeutics, Inc. functions as a clinical-phase biopharmaceutical... Rapport Therapeutics, Inc. functions as a clinical-phase biopharmaceutical enterprise, concentrating its efforts on discovering and developing innovative small-molecule therapeutics for individuals living with central nervous system (CNS) disorders. Its flagship product candidate, RAP-219, is an experimental small molecule precisely designed to inhibit TARPy8-containing AMPARs with exceptional potency (picomolar affinity). This promising compound aims to treat focal epilepsy and a range of other neurological conditions, including peripheral neuropathic pain and bipolar disorder. The company's pipeline further includes RAP-199, another molecule targeting TARPy8, which boasts distinct chemical and pharmacokinetic profiles. Moreover, Rapport is advancing several nicotinic acetylcholine receptor (nAChR) programs, such as an a6 nAChR therapy for chronic pain and an a9a10 nAChR treatment intended for hearing impairments. Formed in 2022 under the initial name Precision Neuroscience NewCo, Inc., the company adopted its current identity as Rapport Therapeutics, Inc. in October 2022, and its operations are based in Boston, Massachusetts.
Prezzo delle azioni
$52.78
Ultima sincronizzazione: 2026-08-26
Capitalizzazione di mercato
$2.52B
Variazione (1 giorno)
3.14%
Variazione (1 anno)
252.56%
Paese
US
Scambia Rapport Therapeutics, Inc. Common Stock (RAPP)

Categoria

Healthcare
Storico dividendi per Rapport Therapeutics, Inc. Common Stock (RAPP)
Rapport Therapeutics, Inc. Common Stock (simbolo azionario: RAPP) ha effettuato un totale di 0 pagamenti di dividendi.
La somma totale dei dividendi (rettificata per split azionari) è: 0.00
Rendimento da dividendo (TTM): 0
Pagamenti dei dividendi per Rapport Therapeutics, Inc. Common Stock (RAPP) dal 2026 al 2026
Pagamenti annuali dei dividendi
Anno Dividendo (rettificato per split azionari) Cambia
Non abbastanza dati per le date fornite.
Elenco di tutti i pagamenti di dividendi
Anno Dividendo Cambia
Non abbastanza dati per le date fornite.
Dividendi di aziende simili o concorrenti
Azienda Numero di pagamenti di dividendi Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH